Bibliografía del artículo
1. Campbell E, Colton J. Warts and tubercles occurring on the penis or other parts of the body; corns and black warts. En: The Surgery of Theodoric Ca. A. D. 1267. New York, EE.UU.: Appleton-Century-Crofts; 1960. p. 109-114. (vol II). 2. Dunsmuir WD, Kirby RS. Francois de La Peyronie (1678-1747): The man and the disease he described (historical review). Br. J. Urol 78:613, 1996.
3. La Peyronie F. Sur quelques obstacles qui sopposent a lejaculation naturelle de la semence. Paris, Francia: Mein de lAcadamie Royale de Chir; 1743. p. 425-434
4. Kuss R, Gregoir W, Linduration plastique des corps caverneux. En Histoire illustree de l'urologie de l'antiquite a nos jours. Paris, Francia: Roger Dacosta; 1984. p. 425.
5. Chevallier D, Nizri E, Olpe P y col. A Peyronie disease. Historical, epidemiological, physiopatological data. Diagnostic and therapeutic approaches. Rev Med Int 18:41, 1997.
6. Zargooshi J, Trauma as the cause of Peyronies disease: penile fracture as a model of trauma. J Urol 172:186, 2004.
7. Devine CJ Jr, Somers KD, Jordan SG y col. Proposal: trauma as the cause of the Peyronies lesion. Journal of Urology 157:285, 1997.
8. Hellstrom WJG, Bivalacqua TJ. Enfermedad de Peyronie: etiología, médica y terapia quirúrgica. J Androl 21:347, 2000.
9. Ralph DJ, Minhas S. BJU Int. Aetiopathogenesis and therapy for Peyronies disease are summarized below. The management of Peyronies disease. Institute of Urology, UK. 93:208, 2004.
10. Schwartz Velasco A, Muñoz Reyes JA, Pérez P y col. Laserterapia para el tratamiento de la enfermedad de Peyronie (induración plástica del pene). Bol Col Mex Urol 11:190, 1994.
11. Matern R, Bivalacqua TJ, Sikka S y col. Intralesional interferon-alpha-2B injections for the treatment of Peyronies disease. Med J 97:42, 2004.
12. Adams DM, Hellstrom WJ. Intralesional interferon-alpha-2b for the treatment of Peyronies disease. Int J Impot Res 14:336, 2002.
13. Brake M, Loertzer H, Horsch R y col. Treatment of Peyronies disease with local interferon-alpha 2b. BJU Int 87:654, 2001.
14. Morales Martín A, Abal Chatada V y col. Enfermedad de La Peyronie y otras alteraciones morfométricas del pene. Tema monográfico. LXVI Congreso Nacional de Urología. Asoc Esp Urol, 2001.
15. Rodriguez Tolra J, Franco Miranda E, Prats Puig JM y col. Treatment with the Nesbit technique in patients with Peyronies disease (article in spanish). Actas Urol Esp 7:803, 2003.
16. Cruceyra Betriu G, Duarte Ojeda JM, Martínez Silva V. y col. Penile tunica albuginea plication for the treatment of penile curvature secondary Peyronies disease (article in spanish). Arch Esp Urol 58:445, 2005.
17. Kalsi J, Minhas S, Christopher N. y col. The results of plaque incision and venous grafting (Lue procedure) to corrective penile deformity of Peyronies disease. BJU Int 95:1029, 2005.
18. Raimoldi A, Berti GL, GIOLA V y col. Our experience in the treatment of penile curvature. Arch Ital Urol Androl 76:66, 2004.
19. Bokarica P, Parazajder J, Mazuran B., y col. Surgical treatment of Peyronies disease based on penile length and degree of curvature. Int J Impot Res 17:170, 2005.
20. Tornehl CK, Carson CC. Surgical alternatives for treating Peyronies disease. BJU Int 94:774, 2004.
21. Navalon Verdejo P, Zaragoza Fernández C, Sánchez Ballester F y col. Correction of the penile curvature in ambulatory surgery (article in spanish). Actas Urol Esp 29:217, 2005.
22. Portillo Martín JA, Correas Gómez MA, RADO VELÁSQUEZ MA y col. Corrective surgery of penile inward curvatura (article in spanish). Actas Urol Esp 27:97, 2003.
23. Hellstrom WJG, REDDY S. Aplicación del injerto pericárdiaco en el tratamiento quirúrgico de la enfermedad de Peyronie. J Urol 163:1445, 2000.
24. Rosales CS, Ramírez G, Morales Barturen SM y col. Avances en el tratamiento de la enfermedad de La Peyronie. Revista de Postgrado de la VI a Cátedra de Medicina 148, 2005.
25. Mester E, Juhasz J, Varga P y col. Lasers in clinical pratice. Acta Chirurgica Academ Humgaria 9:349, 1968.
26. Mester E, Mester AF, Mester A. The biomedical effects of laser applications. Laser in Surgery and Medicine 5:31, 1985.
27. Troup G. Láseres y másseres. 2a ed. Madrid, España: Paraninnfo; 1969.
28. Duncan, MR, Berman B, Nseyo VO. Regulation of the proliferation and biosynthetic activities of cultured human Peyronies disease fibroblasts by interferons-alpha-beta and gamma. Scand J Urol Nephrol 25:89, 1991.
29. Felipetto R, Vigano L, Pagni G y col. Laser and ultrasonic therapy in simultaneous emission for the treatment of plastic penile induration. Minerva Urol Nefrol 47:25, 1995.
30. Wegner HE, Andresen R y col. Treatment of Peyronies disease with local interferon alpha-2b. Eur Urol 28:336, 1995.
31. Judge JS, Wisniewski ZS. Intralesional interferon in the treatment of Peyronies disease: a pilot study. Br J Urol 79:40, 1997.
32. Andresen R, Wegner HE, Banzer D y col. Ultrasound and soft-tissue radiography to monitor local interferon-alpha 2b treatment in Peyronies disease. Acta Radiol 37:352, 1996.
33. Díaz García F, Rojas Soular Y, Rodríguez Díaz J. Valor del ultrasonido diagnóstico en la enfermedad de Peyronie. Medisan 4:36, 2000.
34. Fornara P, Gerbershagen HP. Ultrasound in patients affected with Peyronies disease. J Urol 22:365, 2004.
35. Schwarzer U, Sommer F, Klotz T. y col. La enfermedad de la Peyronie: resultados de un examen grande. BJU 88:727, 2001.
36. Pourbagher MA, Turunc T, Pourbagher A y col. Peyronie disease involving the entire tunica albuginea of the penis. Department of Radiology, J Ultrasound Med 24:387, 2005.
37. Weidner W, Hauck EW, Schnitker J. Potassium paraaminobenzoate (POTABA) in the treatment of Peyronies disease: a prospective, placebo-controlled, randomized study. Peyronies Disease Study Group of Andrological Group of German Urologists. Eur Urol 47:530, 2005.
38. Di Stasi SM, Giannantoni A, Stephen RL y col. Prospective, randomized study using transdermal electromotive administration of verapamil and dexamethasone for Peyronies disease. J Urol 171:1605, 2004.
39. Lemourt Oliva M, Rodríguez Barroso A, Bordonado Ramírez R y col. Study of propoleum dosage in Peyronies disease (article in spanish). Arch Esp Urol 56:814, 2003.
40. Claro JA, Passerotti CC, Figueiredo Neto AC y col. An alternative non-invasive treatment for Peyronies disease. J Urol 30:199, 2004.
41. Skolarikos A, Alargof E, Rigas A y col. Shockwave therapy as first-line treatment for Peyronies disease: a prospective study. J Endourol 19:11, 2005.
42. Perugia G, LIBERTI M, Vicini P y col. Role of hyperthermia in the treatment of Peyronies disease: a preliminary study. Int J Hyperthermia 21:367, 2005.
43. Pérez Espejo M, Campoy Martínez P, Pérez Pérez M y col. Iontophoresis in Peyronies disease. Our experience (article in spanish). Arch Esp Urol 56:1133, 2003.
44. Wang Z, Liu JF, Zhou ZH y col. Gene expression profiles and effects of transforming growth factor-beta1 intervention in Peyronies disease (article in chinese). Zhonghua Wai Ke Za Zh 42:182, 2004.
45. Zhao F, LI H, Zhonghua NKX. Advances in the research of Peyronies disease (article in chinese). Zhonghua Nan Ke Xue 10:378, 2004.